These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 23948938

  • 1. Involvement of insulin-degrading enzyme in insulin- and atrial natriuretic peptide-sensitive internalization of amyloid-β peptide in mouse brain capillary endothelial cells.
    Ito S, Ohtsuki S, Murata S, Katsukura Y, Suzuki H, Funaki M, Tachikawa M, Terasaki T.
    J Alzheimers Dis; 2014; 38(1):185-200. PubMed ID: 23948938
    [Abstract] [Full Text] [Related]

  • 2. Atrial natriuretic peptide is eliminated from the brain by natriuretic peptide receptor-C-mediated brain-to-blood efflux transport at the blood-brain barrier.
    Ito S, Ohtsuki S, Katsukura Y, Funaki M, Koitabashi Y, Sugino A, Murata S, Terasaki T.
    J Cereb Blood Flow Metab; 2011 Feb; 31(2):457-66. PubMed ID: 20628403
    [Abstract] [Full Text] [Related]

  • 3. Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovascular endothelial cell cultures.
    Lynch JA, George AM, Eisenhauer PB, Conn K, Gao W, Carreras I, Wells JM, McKee A, Ullman MD, Fine RE.
    J Neurosci Res; 2006 May 15; 83(7):1262-70. PubMed ID: 16511862
    [Abstract] [Full Text] [Related]

  • 4. Modulation of Amyloid-β1-40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier.
    Merino-Zamorano C, Fernández-de Retana S, Montañola A, Batlle A, Saint-Pol J, Mysiorek C, Gosselet F, Montaner J, Hernández-Guillamon M.
    J Alzheimers Dis; 2016 May 25; 53(2):677-91. PubMed ID: 27232214
    [Abstract] [Full Text] [Related]

  • 5. Brain insulin impairs amyloid-beta(1-40) clearance from the brain.
    Shiiki T, Ohtsuki S, Kurihara A, Naganuma H, Nishimura K, Tachikawa M, Hosoya K, Terasaki T.
    J Neurosci; 2004 Oct 27; 24(43):9632-7. PubMed ID: 15509750
    [Abstract] [Full Text] [Related]

  • 6. Characterization of human platelet receptors for atrial natriuretic peptide: evidence for clearance receptors.
    Blaise V, Wolf JP, Regnard J, Berthelay S.
    Cell Mol Biol (Noisy-le-grand); 1996 Dec 27; 42(8):1173-9. PubMed ID: 8997521
    [Abstract] [Full Text] [Related]

  • 7. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S.
    Proc Natl Acad Sci U S A; 2003 Apr 01; 100(7):4162-7. PubMed ID: 12634421
    [Abstract] [Full Text] [Related]

  • 8. Reduced amyloid-β degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models.
    Stargardt A, Gillis J, Kamphuis W, Wiemhoefer A, Kooijman L, Raspe M, Benckhuijsen W, Drijfhout JW, Hol EM, Reits E.
    Aging Cell; 2013 Jun 01; 12(3):499-507. PubMed ID: 23534431
    [Abstract] [Full Text] [Related]

  • 9. Non-covalent interaction of ubiquitin with insulin-degrading enzyme.
    Saric T, Müller D, Seitz HJ, Pavelic K.
    Mol Cell Endocrinol; 2003 Jun 30; 204(1-2):11-20. PubMed ID: 12850277
    [Abstract] [Full Text] [Related]

  • 10. [Structure and function of the receptor for human atrial natriuretic peptide in cultured human skin fibroblasts].
    Ohashi M, Hashiguchi T, Takayanagi R, Haji M, Nawata H.
    Fukuoka Igaku Zasshi; 1990 Oct 30; 81(10):331-6. PubMed ID: 2175731
    [Abstract] [Full Text] [Related]

  • 11. Gestational hypertension in atrial natriuretic peptide knockout mice and the developmental origins of salt-sensitivity and cardiac hypertrophy.
    Armstrong DW, Tse MY, O'Tierney-Ginn PF, Wong PG, Ventura NM, Janzen-Pang JJ, Matangi MF, Johri AM, Croy BA, Adams MA, Pang SC.
    Regul Pept; 2013 Sep 10; 186():108-15. PubMed ID: 23981445
    [Abstract] [Full Text] [Related]

  • 12. Increased efflux of amyloid-β peptides through the blood-brain barrier by muscarinic acetylcholine receptor inhibition reduces pathological phenotypes in mouse models of brain amyloidosis.
    Paganetti P, Antoniello K, Devraj K, Toni N, Kieran D, Madani R, Pihlgren M, Adolfsson O, Froestl W, Schrattenholz A, Liebner S, Havas D, Windisch M, Cirrito JR, Pfeifer A, Muhs A.
    J Alzheimers Dis; 2014 Sep 10; 38(4):767-86. PubMed ID: 24072071
    [Abstract] [Full Text] [Related]

  • 13. LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier.
    Pflanzner T, Janko MC, André-Dohmen B, Reuss S, Weggen S, Roebroek AJ, Kuhlmann CR, Pietrzik CU.
    Neurobiol Aging; 2011 Dec 10; 32(12):2323.e1-11. PubMed ID: 20630619
    [Abstract] [Full Text] [Related]

  • 14. Atrial natriuretic peptide-mediated inhibition of microcirculatory endothelial Ca2+ and permeability response to histamine involves cGMP-dependent protein kinase I and TRPC6 channels.
    Chen W, Oberwinkler H, Werner F, Gaßner B, Nakagawa H, Feil R, Hofmann F, Schlossmann J, Dietrich A, Gudermann T, Nishida M, Del Galdo S, Wieland T, Kuhn M.
    Arterioscler Thromb Vasc Biol; 2013 Sep 10; 33(9):2121-9. PubMed ID: 23814119
    [Abstract] [Full Text] [Related]

  • 15. Atrial natriuretic peptide protects against histamine-induced endothelial barrier dysfunction in vivo.
    Fürst R, Bubik MF, Bihari P, Mayer BA, Khandoga AG, Hoffmann F, Rehberg M, Krombach F, Zahler S, Vollmar AM.
    Mol Pharmacol; 2008 Jul 10; 74(1):1-8. PubMed ID: 18413663
    [Abstract] [Full Text] [Related]

  • 16. Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice.
    Gali CC, Fanaee-Danesh E, Zandl-Lang M, Albrecher NM, Tam-Amersdorfer C, Stracke A, Sachdev V, Reichmann F, Sun Y, Avdili A, Reiter M, Kratky D, Holzer P, Lass A, Kandimalla KK, Panzenboeck U.
    Mol Cell Neurosci; 2019 Sep 10; 99():103390. PubMed ID: 31276749
    [Abstract] [Full Text] [Related]

  • 17. Binding of atrial and brain natriuretic peptides to cultured mouse astrocytes from different brain regions and effect on cyclic GMP production.
    Yeung VT, Ho SK, Leung DH, Stadlin A, Nicholls MG, Cockram CS.
    Glia; 1993 Dec 10; 9(4):243-7. PubMed ID: 7509312
    [Abstract] [Full Text] [Related]

  • 18. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.
    Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z, Peng Y, Cambareri G, Rocher A, Mobbs CV, Hof PR, Pasinetti GM.
    FASEB J; 2004 May 10; 18(7):902-4. PubMed ID: 15033922
    [Abstract] [Full Text] [Related]

  • 19. Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier.
    Bachmeier C, Beaulieu-Abdelahad D, Mullan M, Paris D.
    Mol Cell Neurosci; 2013 Sep 10; 56():255-62. PubMed ID: 23831388
    [Abstract] [Full Text] [Related]

  • 20. Insulin degrading enzyme is expressed in the human cerebrovascular endothelium and in cultured human cerebrovascular endothelial cells.
    Gao W, Eisenhauer PB, Conn K, Lynch JA, Wells JM, Ullman MD, McKee A, Thatte HS, Fine RE.
    Neurosci Lett; 2004 Nov 16; 371(1):6-11. PubMed ID: 15500957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.